Results 101 to 110 of about 12,210 (151)

Measurement of Acute Intraocular Pressure Elevation Immediately After Intravitreal Anti-VEGF Injection and Analysis of Prefilled Syringe Accuracy. [PDF]

Clin Ophthalmol
Itoh K, Negishi M.
europepmc   +1 more source

Efficacy and factors associated with reactivation following intravitreal ranibizumab or conbercept for retinopathy of prematurity. [PDF]

Front Med (Lausanne)
Liu Q, Li J, Liu J, Xie S, Mu G, Zhao H, Zheng J, Huang X, Wang J.   +8 more
europepmc   +1 more source

Efficacy and Safety of Anti-vascular Endothelial Growth Factor (VEGF) Agents in Diabetic Macular Edema. [PDF]

Cureus
Krishnan B V, Kauser N, Priya G, Sm M.
europepmc   +1 more source

Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]

Front Med (Lausanne)
Ji M, Wei W, Gong H, Zhang G.
europepmc   +1 more source

Impact of Intravitreal Ranibizumab on Retinopathy of Prematurity: A Retrospective Analysis. [PDF]

Cureus
Nitta F, Kunikata H, Watanabe S, Nakazawa T.   +3 more
europepmc   +1 more source

Comparison of the clinical effect of intravitreal ranibizumab and intravitreal dexamethasone implants in the treatment of retinal vein occlusion complicated with macular oedema: a meta-analysis. [PDF]

BMC Ophthalmol
Li Y, Hu L, Zu J.
europepmc   +1 more source

Effects of Subconjunctival Bevacizumab and Ranibizumab on Corneal and Systemic Oxidative Stress Biomarkers in an Alkali Injury Model. [PDF]

Life (Basel)
Yarbağ A, Bardaş Özkan E, Ulaş M, Arslan YK.   +3 more
europepmc   +1 more source

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy. [PDF]

Pharmacotherapy
Clements JN, Mesawich J, Twisdale C.
europepmc   +1 more source

Comparative evaluation of stability, efficacy, and sterility in five repackaged intravitreal anti-vascular endothelial growth factor medications. [PDF]

Sci Rep
Thunwiriya P, Phetruen T, Chaiwijit P, Tonawannakorn C, Dekham K, Thadtapong N, Chaturongakul S, Charoensawan V, Chanarat S, Pakotiprapha D, Hanutsaha P.   +10 more
europepmc   +1 more source

Assessing the Safety and Efficacy of Agonistic Monoclonal Antibody against Robo4 versus Ranibizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Phase I, Open-Label, Multicenter Study. [PDF]

Ophthalmol Sci
Afridi R, Senaldi G, Hwang JJ, Nguyen N, Inoue T, Berger B, Patel S, Fazal ZZ, Nguyen QD, Sepah Y.   +9 more
europepmc   +1 more source